Cardiovascular Rehabilitation After Infrarenal Aortic Aneurysm Repair (REHAB-AAA)

July 7, 2026 updated by: Medical University Innsbruck

Cardiovascular Rehabilitation After Infrarenal Aortic Aneurysm Repair-REHAB-AAA, a Randomised Controlled Pilot Study

Evidence about the benefit of cardiovascular rehabilitation (CR) after open or endovascular repair of an infrarenal aortic aneurysm is lacking. The positive effect of CR on the cardiovascular fitness, quality of life and mortality is well established in other cardiovascular fields like cardiac surgery.

The aim of this study is to determine whether participation in a structured CR, compared with standard postoperative care (SC), results in greater improvements in cardiorespiratory fitness in patients following abdominal aortic aneurysm repair.

The study will also evaluate whether CR, compared with SC, improves health-related quality of life, reduces cardiovascular risk-factors and adverse cardiovascular events and preserves of cognitive function over the follow-up period. Furthermore, the number of complications and reoperations will be evaluated.

Study Overview

Status

Not yet recruiting

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with an abdominal aortic aneurysm (AAA) and an indication for repair, ability to understand and willingness to sign a written informed consent document.

Exclusion Criteria:

  • Acute AAA repair
  • AAA size ≥7cm
  • Para/suprarenal AAA
  • AAA due to a connective tissue disorder
  • Impaired mobility
  • Life expectancy <12 months
  • Severe co-morbidities influencing or preventing CR (e.g. ≥COPD II, PAD ≥ Rutherford 3, dialysis)
  • Participation in another interventional study that may confound the study endpoints
  • Patients <18 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cardiovascular rehabilitation
This group receives a three-week inpatient cardiovascular rehabilitation program three months after the procedure.
Participants after open or endovascular abdominal aortic aneurysm repair will receive a three-week inpatient structured cardiovascular rehabilitation program three months after the procedure.
Other Names:
  • cardiovascular rehabilitation
No Intervention: Standard care
Participants assigned to standard care will be advised to optimize their cardiovascular risk factors and to engage in regular moderate-intensity cardiovascular exercise; however, no supervised cardiovascular rehabilitation or structured exercise program will be prescribed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of VO2max
Time Frame: Before the procedure and 1 year after aortic repair
Maximal oxygen uptake
Before the procedure and 1 year after aortic repair
6-minute walking distance (6MWD)
Time Frame: Before the procedure and 1 year after aortic repair
Walking distance after 6 minutes
Before the procedure and 1 year after aortic repair

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of the results of the The Short Form (36) Health Survey (SF-36) questionnaire
Time Frame: Before surgery and 1 year after aortic repair
Quality of life questionnaire evaluating 36 items on a scale of 0-100. A score of 0 is equivalent to maximum disability and a score of 100 is equivalent to no disability
Before surgery and 1 year after aortic repair
Surgery related complications and reoperations
Time Frame: After 30 days and after 1 year after aortic repair.
Number of surgically related complications and reoperations
After 30 days and after 1 year after aortic repair.
Change of blood pressure
Time Frame: Blood pressure and serum lipid profile preoperative and 1 year after aortic repair.
Blood pressure and serum lipid profile preoperative and 1 year after aortic repair.
Mini-mental state examination
Time Frame: Preoperative and 1 year after aortic repair.
Change of the mini-mental-score (0-30 points). Any score of 24 or more indicates a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10-18 points) or mild (19-23 points) cognitive impairment.
Preoperative and 1 year after aortic repair.
Major adverse cardiovascular events (MACE)
Time Frame: 30 days and 1 year after aortic repair.
Number of composite adverse cardiovascular events: non-fatal myocardial infarction, stroke, coronary and peripheral arterial disease revascularization, non-traumatic amputation
30 days and 1 year after aortic repair.
Serum lipid profile
Time Frame: Blood pressure and serum lipid profile preoperative and 1 year after aortic repair.
Blood pressure and serum lipid profile preoperative and 1 year after aortic repair.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michaela Enzmann, MD, Department of Vascular Surgery, Medical University of Innsbruck, Austria

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

January 1, 2029

Study Completion (Estimated)

April 1, 2029

Study Registration Dates

First Submitted

June 22, 2026

First Submitted That Met QC Criteria

July 7, 2026

First Posted (Actual)

July 8, 2026

Study Record Updates

Last Update Posted (Actual)

July 8, 2026

Last Update Submitted That Met QC Criteria

July 7, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Study relevant pseudonymized IPD will be shared by the study team upon reasonable request.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Abdominal Aortic Aneurysm

Clinical Trials on Structured cardiovascular rehabilitation

3
Subscribe